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Abstract
The CD3ε cytoplasmic tail contains a conserved proline-rich sequence (PRS) that influences
TCR–CD3 expression and signaling. Although the PRS can bind the SH3.1 domain of the
cytosolic adapter Nck, whether the PRS is constitutively available for Nck binding or instead
represents a cryptic motif that is exposed via conformational change upon TCR–CD3 engagement
(CD3Δc) is currently unresolved. Furthermore, the extent to which a cis-acting CD3ε basic amino
acid-rich stretch (BRS), with its unique phosphoinositide-binding capability, might impact PRS
accessibility is not clear. In this study, we found that freshly harvested primary thymocytes
expressed low to moderate basal levels of Nck-accessible PRS (“open-CD3”), although most
TCR–CD3 complexes were inaccessible to Nck (“closed-CD3”). Ag presentation in vivo induced
open-CD3, accounting for half of the basal level found in thymocytes from MHC+ mice.
Additional stimulation with either anti-CD3 Abs or peptide–MHC ligands further elevated open-
CD3 above basal levels, consistent with a model wherein antigenic engagement induces maximum
PRS exposure. We also found that the open-CD3 conformation induced by APCs outlasted the
time of ligand occupancy, marking receptors that had been engaged. Finally, CD3ε BRS–
phosphoinositide interactions played no role in either adoption of the initial closed-CD3
conformation or induction of open-CD3 by Ab stimulation. Thus, a basal level of open-CD3 is
succeeded by a higher, induced level upon TCR–CD3 engagement, involving CD3Δc and
prolonged accessibility of the CD3ε PRS to Nck.
The TCR is a heterodimer composed of α and β subunits (or γ and δ in γδ T cells) that binds
specifically to Ags in the form of peptides presented by MHC on the surfaces of APCs.
Although the TCR lacks an intrinsic capacity to transduce signals to the cytoplasm, it is
noncovalently associated with the CD3 complex, a group of four transmembrane proteins
(CD3ε, γ, δ, and ζ). These proteins have long cytoplasmic tails that each contain one or
multiple copies of the ITAM (1). TCR engagement by peptide–MHC (pMHC) ligands
induces phosphorylation of CD3 ITAMs by src-family tyrosine kinases (1). However, prior
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to ITAM phosphorylation, the precise mechanism(s) by which the TCR initially
communicates the event of Ag recognition to the CD3 complex is incompletely understood
(2).
Among several nonexclusive models, conformational change of TCR–CD3 has been
proposed as a mechanism that might confer Ag recognition (3, 4). Using a biochemical
approach, it was reported that TCR engagement induced the exposure of what appeared to
be a cryptic proline-rich sequence (PRS) in the CD3ε cytoplasmic tail, a sequence that can
mediate the interaction of CD3ε with the SH3.1 domain of the cytoplasmic adapter protein
Nck (5). At the time, PRS exposure was interpreted to result from a conformational change
in CD3 (CD3Δc) because it occurred prior to and independent of ITAM phosphorylation.
Subsequent studies showed that CD3Δc was inducible by either anti–TCR–CD3 Abs or
cognate pMHC ligands, irrespective of whether thymocytes were stimulated with selection
ligands or mature T cells were stimulated with antigenic ligands (6–8). In absence of
comprehensive structural information, the PRS-accessible CD3 conformation was termed
“open-CD3” and the PRS-inaccessible conformation “closed-CD3” (6). Using soluble
ligands including pMHC tetramers, one study showed that the open and closed CD3
conformations were instantaneously reversible, open-CD3 being adopted upon ligation and
reverting to closed-CD3 upon ligand dissociation (9).
Originally implicated in synapse formation and T cell activation (5), the function of the
CD3ε PRS has subsequently been studied in greater detail. Whereas initial studies using
polyclonal retrogenic mice showed no apparent difference between PRS wild-type versus
mutant-bearing T cells (10), retrogenic mice expressing mutant PRS associated with certain
TCR clonotypes have shown this sequence is required to amplify signals from weak pMHC
ligands (11). More recently, the use of transgenic mice has shown defects in responsiveness
to weak TCR ligands and in the positive selection of thymocytes deficient for the PRS (12).
In another study, where the induction of conformational change was isolated as a single
variable and PRS exposure was monitored as evidence of CD3Δc, both open-CD3 and
receptor aggregation were shown to be required for optimal T cell signaling (9). Taken
together, the PRS is thought to play an important role in TCR–CD3 receptor biology by
functioning in concert with other signaling sequences and mechanisms that collectively
respond to antigenic engagement.
However, some recent work has called into question several critical elements of the
conformational model described above. One group reported that in C57BL/6 (B6) wild-type
(WT) thymocytes, the CD3ε PRS seemed constitutively exposed, and anti-CD3 stimulation
did not significantly increase open-CD3 (12). PRS deficiency was shown to correlate with
increased TCR–CD3 expression, implying that the PRS controls constitutive expression of
the receptor in double-positive (DP) thymocytes. Independent work has since corroborated
the role of the CD3ε PRS in regulating TCR–CD3 ubiquitylation and expression in DP
thymocytes while additionally demonstrating PRS activity in promoting proliferation of
double-negative thymocytes (13–16). Considering all studies together, it is currently not
clear whether the initial interpretation that CD3Δc is required to induce PRS accessibility is
correct, whether thymocytes are unique by expressing the PRS in a constitutively accessible
conformation, or whether differences in experimental systems account for the discrepant
observations (17). Because it is agreed that the CD3ε PRS is functionally relevant to TCR–
CD3 expression and the efficiency of thymic development, the issue of whether this
sequence is constitutively versus inducibly accessible to Nck is currently considered a
significant outstanding question in the field of TCR triggering (2).
A second recently described cytoplasmic motif of CD3ε may also be implicated in TCR
signaling, possibly involving CD3Δc. A basic amino acid-rich stretch (BRS) in the
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juxtamembrane region of the CD3ε cytoplasmic tail can mediate interaction with select
phosphoinositides that are present at different locations in the cell including the inner leaflet
of the plasma membrane (18, 19). One study showed that upon membrane interaction, the
tyrosines of the CD3ε ITAM were bound to the nonpolar phase of the lipid bilayer,
inaccessible to src kinases (18). Because the capacity to interact with phospholipids is
shared with CD3ζ (20, 21), it has been proposed that TCR engagement might result in the
release of membrane-sequestered CD3 ITAMs from the lipid bilayer to facilitate their
phosphorylation (2, 18, 22, 23). Two possibilities have been suggested that might achieve
this: i) mobilization of engaged TCR–CD3 to a different, non-CD3-binding lipid
microenvironment (18, 22) or ii) CD3 conformational change to move CD3 tails from the
membrane to the cytoplasm (2, 23). Because open-CD3 has been proposed to result from
such a conformational change, perhaps the CD3ε BRS, by interacting with the plasma
membrane, may be required to conceal the PRS in the absence of receptor engagement.
In the current work, we have focused on clarifying the extent to which PRS accessibility to
Nck is influenced by constitutive expression, TCR–CD3 engagement, and the CD3ε BRS
motif. Several different experimental systems have been used to resolve these issues and
provide explanations, where possible, as to the reasons why some previous data appeared to
conflict. This work now allows both previous and new results to be resolved into an updated
model of how TCR–CD3 and pMHC ligands together control CD3Δc and PRS accessibility
to Nck. We propose that this model contributes to our understanding of the initial Ag
recognition events associated with TCR triggering.
Materials and Methods
DNA constructs and mice
The construct pGEX-4T1-GST-SH3.1α (SH3.1 derived from human Nck-α) was kindly
provided by Dr. R. Geha (Children’s Hospital, Harvard Medical School, Boston, MA). B6
mice were purchased from The Jackson Laboratory. B6 mice deficient for MHC class II β-
chain and β2-micro-globulin (Abb−/− β2m−/−) were purchased from Taconic. Mice
transgenic for CD3ε BRS WT or CD3ε BRS-Substitute have been previously described (19),
having been bred to the CD3ε−/− background (24). OT-I Rag−/− β2m−/− mice were kindly
provided by Terry Potter (National Jewish Health, Denver, CO). All mice were used
between 6 and 12 wk of age. Mouse procedures were approved by the Mayo Institutional
Animal Care and Use Committee and are consistent with National Institutes of Health
guidelines for the care and use of animals.
Abs and other reagents
The mAb anti-CD3ζ (H146) was kindly provided by Ed Palmer (University Hospital-Basel,
Basel, Switzerland). The rabbit serum anti-MHC class I (α-P8) was kindly provided by
Hidde L. Ploegh (Whitehead Institute for Biomedical Research, Massachusetts Institute of
Technology, Cambridge, MA). The mAb anti-Vα2 was purified from supernatant of the
hybridoma B20.1. Abs from BD Biosciences included anti-TCRβ (H57), anti-Thy1.2
(53-2.1), anti-CD4 (RM4-5), anti-CD8α (53.6.7), anti-CD69 (H12F3), anti-CD3ε (2C11),
and anti–H2-Kd (SF1-1.1). Monoclonal anti-CD3ε APA1/1 was obtained in purified,
unconjugated form from GE Biosciences, PE-labeled from BD, and Alexa Fluor (AF)-555
labeled from Upstate Biotech. Other reagents included serum ham IgG control (Jackson
ImmunoResearch), streptavidin AF-488 and AF-647 (Invitrogen), True Stain FcX
(Biolegend), GSH Sepharose and protein G Sepharose (GE Biosciences), goat serum (Sigma
Chemical), Brij-58 (Sigma Chemical), and Digitonin (Sigma Chemical).
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Cell lines and peptide loading
The T1.4 CD8+ hybridoma expresses the T1 TCR specific for the H-2Kd restricted peptide
from Plasmodium berghei (PbCs 252–260: SYIPSAEKI) chemically conjugated with
photoreactive 4-azidobenzoic acid (ABA) (25, 26). The peptide PbCs 252–260-ABA
(pSYIP) was produced following protocols described elsewhere (26). The murine
mastocytoma P815 (American Type Culture Collection) expresses H-2Kd and was used as
APC for T1 hybridoma cells. T2-Kb cells [kindly provided by T. Potter (27)], express H-2Kb
and were used as APCs for OT-I cells. The H2-Kb restricted peptides pFARL (SSIEFARL)
and pOVA (SIINFEKL) were purchased from Elim Biopharmaceuticals. All peptides were
loaded at 2 µM into their respective APCs for 2 h. After loading, APCs were washed once to
remover excess peptide prior to coculture with thymocytes.
Thymocyte stimulation
When mouse thymocytes were stimulated with soluble Abs to induce open-CD3, cells were
preincubated on ice with 10 µg/ml of either hamster IgG isotype control (Ham IgG) or anti-
CD3 Ab (2C11) in RPMI medium supplemented with 5% FBS for 10 min and then
incubated for 15 min at 37°C. Stimulation was stopped by sample centrifugation at 4°C
followed by lysis of pelleted cells. Alternatively, thymocytes were lysed prior to induction
of open-CD3 with soluble Abs. In this case, 10 µg/ml of either Ham IgG or 2C11 were
added to the postnuclear fractions of thymocytes at the preclearing step of the CD3 pull-
down assay. OT-I Rag−/− β2m−/− thymocytes and T1 hybridoma cells were stimulated with
peptide-loaded T2-Kb and P-815 APCs, respectively. In this case, both T cells and peptide-
loaded APCs were cocultured in a ratio of 1:1 for 30 min at 37°C to induce open-CD3.
Immediately after stimulation, cocultures were centrifuged at 4°C followed by lysis of
pelleted cells.
CD3 pull-down assay, immunoprecipitation, and Western blot
The CD3 pull-down (CD3-PD) assay was previously described as a means to detect open-
CD3 conformation (5, 6). Briefly, cells were lysed on ice for 30 min using isotonic buffer
containing non-ionic detergents (either 0.3% Brij 58 or 1% Digitonin), and postnuclear
lysates were obtained. A one-tenth fraction of each postnuclear lysate was mixed with an
equal volume of acetone, and the resulting protein precipitates were used to represent the
total CD3 content in each sample (total lysate; TL) by Western blot (WB) for CD3 ζ (H146).
The remainder of each sample was precleared by incubation with GST beads (1 h, 4°C) prior
to specific pull-down with GST-SH3.1 beads (4–12 h, 4°C), followed by SDS-PAGE,
nitrocellulose transfer, and WB for CD3 ζ (H146). Where indicated, APA1/1 was added to
samples during the preclearing step to act as competitive inhibitor of the specific CD3 pull-
down with GST-SH3.1 beads (6) to establish the background open-CD3 detection associated
with this assay. For immunoprecipitation, postnuclear lysates prepared as described above
were incubated with protein G Sepharose beads coupled with Ab during 4–12 h at 4°C. Then
beads were washed extensively and subjected to SDS-PAGE, nitrocellulose transfer, and
WB.
Quantification of open-CD3 conformation
The pixels of CD3ζ bands detected by WB in TL and CD3-PD samples were counted using
the Threshold function and the Magic Wand tool in Adobe Photoshop Elements. Lightest
exposures where weakest bands were detectable were used to count pixels. Threshold was
set such that every band counted was detected as a well-defined single element. A CD3-PD/
TL ratio of pixels was calculated for each sample to determine its content of open-CD3
relative to its total amount of CD3. Basal open-CD3 was calculated as a fold-increase over
open-CD3 found as background of the CD3-PD assay. The induction of open-CD3 by anti-
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CD3 stimulation was calculated as a fold-increase over the amount of open-CD3 observed in
nonstimulated samples. For statistical analysis, five or more independent experiments were
performed, and the central and variance values (arithmetic mean, median, SD, SE) of basal
and stimulated open-CD3 were calculated. Paired t tests were run to calculate p values to
examine possible differences between experimental groups.
Intracellular staining of CD3ε cytoplasmic tail with the mAb APA1/1
Thymocytes from either B6 or Abb−/− β2m−/− mice were stained with anti-Thy1.2–
allophycocyanin, washed extensively, and stimulated with soluble Abs as described earlier.
To provide an in internal negative control for CD3 staining, splenocytes from Abb−/−
β2m−/− mice, prestained with anti-Thy1.2–PercCP and extensively washed, were added to
both types of thymocyte samples. Next, mixtures of thymocytes and splenocytes were fixed
and permeabilized with 10 volumes of Cytofix/Cytoperm kit (BD) for 60 min on ice.
Samples were washed once and resuspended in a blocking buffer consisting of washing
buffer from the Cytofix/Cytoperm kit supplemented with 5% goat serum and True Stain FcX
at 5 µg/ml. Samples were blocked overnight on ice, washed once, and stained for 45 min on
ice with APA1/1–PE (BD) diluted in a range from 1:2 to 1:1024 in the blocking buffer.
Then, samples were washed twice, and cells were analyzed on a BD FACSCalibur flow
cytometer calibrated with RCP-30-5A beads (Spherotech). For confocal microscopy analysis
of APA1/1 staining, OT-I Rag−/− β2m−/− thymocytes were stimulated for 30 min at 37°C
with 5 µm polystyrene latex beads [No. 2-5000; Interfacial Dynamics(28)] that had been
covalently coupled with anti-Vα2 Ab. Stimulation was stopped by adding 10 volumes of
ice-cold Cytofix/Cytoperm kit (BD) to the mixture of cells and beads. Then, samples were
immediately placed on ice and incubated for 60 min. After the fixation/permeabilization
step, samples were washed and blocked as described earlier for flow cytometry. To provide
an internal control for low-level CD3 staining to be compared with stimulated OT-I
thymocytes, samples were mixed with nonstimulated thymocytes from Abb−/− β2m−/− mice
that had been fixed, permeabilized, and blocked in parallel. The resulting samples were
stained for 45 min on ice with APA1/1–AF-555 diluted 1:250 in the blocking buffer. Then,
samples were washed twice, mixed with ProLong Gold (Invitrogen), and mounted onto
coverslips for confocal analysis. Samples were imaged on a Zeiss LSM-510 confocal
microscope. Images were analyzed using ImageJ software.
Results
TCR–CD3 engagement induces open-CD3 in B6 thymocytes
To determine the extent to which TCR–CD3 engagement affects the exposure of the CD3ε
PRS, B6 thymocytes were treated in vitro with either Ham IgG or anti-CD3ε mAb 2C11 in
22 independent experiments. After stimulation, thymocytes were lysed and postnuclear
fractions subjected to the CD3-PD assay, in which the SH3.1 domain of Nck, immobilized
to Sepharose beads, captures TCR–CD3 complexes containing Nck-accessible CD3ε PRS
(open-CD3) (5, 6). The quantity of open-CD3 induced by anti-CD3 stimulation was
calculated relative to the amount of open-CD3 found in nonstimulated thymocytes. We
observed that anti-CD3 stimulation induced increased open-CD3 in all experiments, but the
intensity of this induction was variable. Representative low, intermediate, and high fold-
inductions of open-CD3 found among our experiments are shown in Fig. 1A–C. Over all
experiments, open-CD3 induction ranged from a minimum value of 1.9-fold to a maximum
of 11.5-fold (mean = 4.7, median = 4.4, SD = 2.5, SE = 0.5; Fig. 1D). We conclude that
engagement of the TCR–CD3 complex consistently increases the level of open-CD3 in B6
thymocytes, although this inducibility displays some variance between experiments.
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Nonstimulated B6 thymocytes express basal levels of open-CD3
In the experiments described above, a lower initial level of open-CD3 seemed to be readily
detectable from thymocytes without overt experimental TCR–CD3 engagement (Fig. 1A–
C). We wished to determine whether this apparent open-CD3 was attributable to assay
background (nonspecific CD3 appearing in the pull-down) or true basal expression (specific
PRS-dependent CD3 binding to SH3.1). To distinguish between these two possibilities, we
used the mAb APA1/1, which binds an amino acid sequence in CD3ε that partially overlaps
with the PRS (29), blocking and outcompeting binding to SH3.1 (5, 6). Therefore, any CD3
present in pull-downs performed in the presence of APA1/1 must be independent of the
CD3ε PRS, revealing nonspecific assay background. In 12 independent experiments, we
consistently found that basal open-CD3 was higher than the assay background, and
additionally anti-CD3 treatment induced yet greater open-CD3 levels (Fig. 2A, 2B). These
trends were evident whether the data were analyzed relative to the assay background (Fig.
2B, 2C) or relative to the positive basal level (Fig. 2A). We conclude that freshly isolated B6
thymocytes contain basal levels of open-CD3 expressed in the absence of overt stimulation.
Additionally, upon in vitro TCR–CD3 engagement, increased levels of open-CD3 are
induced (Fig. 2C).
Thymic Ag presentation induces basal open-CD3 in WT thymocytes in vivo
To determine the impact on basal open-CD3 of thymocyte interactions with self-pMHC
ligands, we compared thymocytes from B6 WT and Abb−/− β2m−/− mice. Thymocytes from
the latter cannot engage with Ags due to MHC deficiency (30). CD3-PD experiments were
designed as above, with assay background, basal, and stimulated open-CD3 levels observed
and quantified. As seen above, anti-CD3 stimulation increased the amount of open-CD3
relative to basal conditions in both WT and Abb−/− β2m−/− thymocytes (Fig. 3A). However,
we found that B6 WT displayed a lower fold-induction of stimulated relative to basal open-
CD3 compared with that of B6 Abb−/− β2m−/− thymocytes. Notably, this difference was not
due to differences in stimulated open-CD3 between WT and knockout thymocytes, but
rather to differences in the basal levels of the two groups: relative to the assay background,
B6 WT thymocytes displayed higher basal open-CD3 than B6 Abb−/− β2m−/− thymocytes
(WT = 5.14, Abb−/− β2m−/− = 2.74; Fig. 3A). In contrast, the maximal open-CD3 induced by
anti-CD3 treatment was roughly equivalent (WT = 10.2, Abb−/− β2m−/− = 10.9; Fig. 3A). To
compare data generated in five independent experiments, we considered anti-CD3 treatment
as a maximal open-CD3 condition and analyzed basal open-CD3 as a percentage of this
maximum (Fig. 3A, 3B, % Max. of Stimulated). We found that while WT thymocytes
expressed ~40% maximum basal open-CD3 in these experiments, the absence of MHC
expression reduced basal open-CD3 by approximately half (Fig. 3B). Therefore, the reason
why anti-CD3 produced less fold-induction of open-CD3 in WT versus Abb−/− β2m−/−
thymocytes (Fig. 3C) was because the freshly harvested basal level in WT was already
closer to the maximum, having been increased in vivo by an MHC-dependent mechanism.
These data demonstrate that MHC expression increases thymocyte display of the open-CD3
conformation, arguing that engagement of TCR by thymic Ag presentation induces open-
CD3 in vivo.
The mAb APA1/1 can bind to the CD3ε cytoplasmic tail independently of TCR–CD3
engagement
A second method has been published as a means to detect open-CD3 in intact cells: it
involves the use of the mAb APA1/1 to specifically stain open but not closed CD3 (7, 8, 11,
12). Because some studies have relied on this method, we tested whether accessibility of
APA1/1 to its CD3ε epitope for intracellular staining mimicked the accessibility of the PRS
to SH3.1 in the CD3-PD assay. We compared the two assays in parallel assessing the B6
WTand Abb−/− β2m−/− samples described above. Unexpectedly, we found that
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nonstimulated thymocytes from both mice showed equivalent intracellular APA1/1 staining,
regardless of the dilution of APA1/1 used in the assay (Fig. 4A–C). This result was in
contrast to that of the CD3-PD assay (Fig. 3A), where stimulation was shown to induce
open-CD3. All thymocyte stainings with APA1/1 were compared with that of non-T cell
splenocytes that had been added to each sample prior to the staining procedure, confirming
that APA1/1 behaved as a T cell-specific probe (Fig. 4A). Therefore, in these experiments,
APA1/1 was unable to distinguish open from closed CD3 and rather stained both
nonstimulated and stimulated CD3 complexes equivalently.
We also tested by confocal microscopy whether APA1/1 displayed specificity for engaged
TCR–CD3 complexes. We isolated preselection DP thymocytes from OT-I Rag−/− β2m−/−
mice (31) that were previously shown to undergo CD3Δc upon TCR stimulation (6). These
thymocytes were labeled on ice with anti-Thy1.2 and mixed in a 1:4 ratio with anti-Vα2–
coupled polystyrene latex beads, which can bind the Vα2+ OT1 TCR. Samples were
incubated 30 min at 37°C, followed by addition of ice-cold fixation/permeabilization
solution in excess to halt the stimulation. Next, unlabeled, fixed/permeabilized Abb−/−
β2m−/− thymocytes were added to samples to allow comparison of their low basal open-CD3
with the open-CD3 found in the bead-stimulated OT-I thymocytes. Bead-stimulated OT-I
Rag−/− β2m−/− thymocytes were identified by the colocalization and concentration of both
APA1/1 (marking CD3ε) and anti-Thy1.2 mAb [marking lipid rafts through this GPI-linked
protein (32)] toward the associated bead (Fig. 4D, right panels). We found that not only
bead-stimulated thymocytes but also nonstimulated Abb−/− β2m−/− and bead-unassociated
OT-I Rag−/− β2m−/− thymocytes displayed a positive APA1/1staining at the plasma
membrane (Fig. 4D, left and central panels). We conclude that whereas the CD3-PD assay
specifically detects open-CD3, the APA1/1 staining assay as we have performed it detects
the CD3 complex regardless of TCR–CD3 engagement.
Open-CD3 outlasts TCR engagement by APCs
It was previously shown that open-CD3 induced by soluble TCR–CD3 ligands
spontaneously reverts to the closed conformation upon detachment of the stimulus from the
receptor (9). We wished to determine whether the open-CD3 induced by APCs displayed
this property or alternatively whether APC engagement was capable of stabilizing open-CD3
after ligand dissociation. Because we had detected the induction of open-CD3 by APCs in
OT-I Rag−/− β2m−/− thymocytes in the past (6, 33), we used this system to test whether
MHC ligands would coprecipitate with open-CD3 in the CD3-PD assay. T2-Kb APCs
expressing H-2Kb were preloaded with either the null peptide (pFARL), the antigenic
peptide (pOVA), or no peptide and cocultured with OT-I Rag−/− β2m−/− thymocytes in the
presence or absence of anti-CD3. Subsequent CD3-PD assay showed that both cognate
pOVA and Ab stimulation induced open-CD3 above basal levels in the cocultures (Fig. 5A,
bottom panel). We observed that the open-CD3 induced by soluble anti-CD3 stimulation
coprecipitated the stimulatory Ab itself, indicating that ligand engagement remained intact
throughout the pull-down procedure (Fig. 5A, top panel). However, there was no
coprecipitation of H-2Kb H chain associated with the open-CD3 induced by pOVA (Fig. 5A,
middle panel), indicating that open-CD3 outlived ligand dissociation. Because the
previously cited work that defined an instantaneously reversible open-CD3 used the T1 TCR
system (26), we sought to determine whether our result above was attributable to the use of a
different TCR system. The T1 TCR is restricted to a chemically modified peptide derived
from Plasmodium berghei (pSYIP) presented by H-2Kd. P-815 APCs expressing H-2Kd
were preloaded with either no peptide or the cognate pSIYP and cocultured with T1
hybridoma cells in the presence or absence of anti-CD3. In this experiment, an
immunoprecipitation of the H2-Kd molecule from pSIYP-stimulated samples was included
to examine whether the pSIYP/H2-Kd:TCR–CD3 engaged interaction could survive cell
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lysis and pull-down. Probably due to the low affinity of pMHC:TCR interaction, no
detectable coprecipitation of CD3 with H2-Kd was observable by WB (Fig. 5B). Still, the
resulting CD3-PD assay showed similar results to those obtained in the OT-I system. Ab
stimulation induced open-CD3 above basal levels (Fig. 5B, bottom panel), and the
stimulatory Ab coprecipitated with open-CD3 (Fig. 5B, top panel). In contrast, the pSIYP
stimulation induced open-CD3 as well (Fig. 5B, bottom panel), but there was no
coprecipitation of H-2Kd with the pSIYP-stimulated open-CD3 (Fig. 5B, middle panel).
Taken together, these data provide an example of a high-affinity ligand (anti-CD3) that does
not dissociate from CD3 and a low-affinity ligand (pSIYP/H2-Kd) that does dissociate, yet
in both cases we detect induced open-CD3. Therefore, we conclude that when pMHC from
APC engages TCR, the open-CD3 conformation is induced such that it remains intact
subsequent to the dissociation of the engaging ligand and does not revert instantaneously to
the closed-CD3 conformation.
The CD3ε BRS is not required to conceal the PRS in absence of TCR–CD3 engagement
We wished to examine whether the ability of the CD3ε BRS motif to interact with
phosphoinositides could influence PRS accessibility to Nck. To do so, we compared
thymocytes from B6 mice transgenic for either CD3ε BRS WT or BRS-Substitute (19),
where the substituted amino acids replace the basic residues and abrogate lipid association
(Fig. 6A). Thymocytes were treated in vitro with APA1/1, Ham IgG, or anti-CD3 mAb
2C11 prior to the CD3-PD assay to calculate background, basal, and stimulated open-CD3
levels. In six independent experiments, we found that basal open-CD3 levels were similar in
both mice (average % Max. of Stimulation: BRS WT = 37%, BRS-Substitute = 39%; Fig.
6B, 6C). Moreover, anti-CD3 stimulation induced open-CD3 above basal levels equivalently
(average Open-CD3: BRS WT = 2.8, BRS-Substitute = 3.2; Fig. 6B, 6D). These data
indicate that the phosphoinositide binding capacity of the BRS is not required either for
adoption of the closed-CD3 conformation or for induction of open-CD3 by Ab stimulation.
Discussion
Although the PRS of CD3ε is considered to be of structural and functional importance, there
are currently two opposing ideas that have been published regarding the regulation of its
accessibility to Nck-SH3.1 binding: i) the PRS is constitutively exposed (12, 14); and ii) the
PRS is inducibly exposed via CD3Δc upon TCR–CD3 engagement (5–7). In performing
experiments designed to reconcile these two scenarios, we have determined that both
constitutive and inducible PRS exposure occur, but each at a distinct level. First, our data
confirms that primary thymocytes express a positive basal level of mature αβ TCR–CD3
complexes in the open-CD3 conformation, even in the absence of TCR engagement. Second,
Ag presentation in vivo is capable of inducing open-CD3 and contributing to basal levels in
thymocytes from MHC+ mice. Third, exogenous TCR–CD3 engagement significantly
increases the number of complexes adopting open-CD3 beyond the basal level, consistent
with previous work that focused on this induction as an outcome of CD3Δc.
To arrive at these conclusions, we first revisited the question of whether TCR–CD3
engagement promotes the exposure of the PRS in murine thymocytes. After performing
statistical analysis of data generated by the CD3-PD assay in 22 independent tests, we
established a mean induction of open-CD3 stimulated by anti-CD3 treatment of 4.4-fold the
level of open-CD3 found in nonstimulated thymocytes (Fig. 1C). Thus, we propose that
TCR–CD3 engagement consistently induces CD3Δc in thymocytes, increasing the amount
of Nck-accessible PRS upon stimulation. It is likely that the low inducibility reported
elsewhere by the CD3-PD assay [1.2- to 1.5-fold (12); 1.4- to 1.6-fold (14)] falls within the
low but positive natural variance, consistent with the statistical analysis reported in this
study. However, using an alternative method to the CD3-PD assay for detecting open-CD3
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(7, 8, 11), one group showed that the CD3ε of thymocytes was accessible to the mAb
APA1/1 irrespective of stimulation (12), suggesting again a constitutive exposure of the PRS
[as this motif partially overlaps with the epitope for the mAb (29)]. We replicated their
observation using APA1/1 staining as a readout (Fig. 4); however, by performing the CD3-
PD assay in parallel (Fig. 3), we found that the CD3-PD assay was sensitive to TCR–CD3
engagement in experiments where APA1/1 binding was fully positive regardless of
engagement (Fig. 4A–C). These results indicate that APA1/1 staining and the CD3-PD assay
assess two different properties of CD3ε protein expression and cannot be used
interchangeably by the methods described in this study. In our experiments, APA1/1 bound
CD3ε independently of TCR–CD3 engagement (Fig. 4). Therefore, APA1/1 revealed total
CD3ε protein expression, regardless of stimulation. In contrast, the results of the CD3-PD
assay performed in parallel were dependent on TCR–CD3 engagement (Fig. 3). Therefore,
CD3-PD assay assessed the level of open-CD3 but not total CD3ε protein expression. We
conclude that TCR–CD3 engagement increases the level of PRS accessibility to Nck and is
best observed using an assay that employs the SH3.1Nck domain itself.
To confirm the specificity of basal open-CD3, we compared the level found in
nonstimulated thymocytes with the background of the CD3-PD assay. As an average, levels
of open-CD3 in nonstimulated thymocytes were 5.3-fold higher than the background,
whereas levels in stimulated thymocytes reached 20.8-fold (Fig. 2C). Thus, we observed
basal open-CD3 in nonstimulated thymocytes and distinguished it from the nonspecific
background of the CD3-PD assay (Fig. 2). Because we had previously shown that weak
antigenic engagement induces open-CD3 in preselection DP OT-I thymocytes (6), we
hypothesized that Ags mediating selection in the B6 thymus might cause to some degree
basal open-CD3 in thymocytes. To test this possibility, we compared the basal open-CD3
found in thymocytes isolated from B6 WT and Abb−/− β2m−/− mice, the latter lacking Ag
presentation due to deficiencies in MHC expression. Basal open-CD3 found in B6 Abb−/−
β2m−/− mice was lower than in B6 WT (Fig. 3A, 3B). These data suggest that Ags presented
in the thymus are able to induce open-CD3 in a WT TCR repertoire in vivo. However,
nonstimulated Abb−/− β2m−/− thymocytes still contained half the amount of open-CD3
found in B6 WT thymocytes (Fig. 3A, 3B). Therefore, some basal open-CD3 occurs in the
absence of TCR:pMHC engagement by conventional MHC-based ligands. Basal open-CD3
could sustain the ligand-independent regulation of TCR–CD3 surface expression level in DP
thymocytes proposed in previous reports (12, 13, 16). In addition, different thymocyte
subsets may possibly exhibit distinct levels of open-CD3 that could contribute to the basal
levels we measure from the bulk thymocyte population. For example, some γδ thymocytes
not restricted to MHC-related molecules might still interact with ligands in the thymus of
Abb−/− β2m−/− mice and contribute to basal open-CD3. Alternatively, the pre-TCR
expressed by double-negative thymocytes has been shown to signal in the absence of
engagement by extrinsic ligands (34) and to display open-CD3 in the absence of anti-CD3
stimulation (14). Future experimentation will be required to characterize further basal open-
CD3 and determine its functional impact in diverse thymocyte populations.
A recent study showed that open-CD3 could be induced by soluble pMHC class I tetramers,
but the conformation reverted to closed-CD3 as soon as the TCR lost contact with the ligand
(9). In those experiments, positive capture of open-CD3 also coprecipitated the engaging
ligand MHC class I (MHC-I), as assessed by the CD3-PD assay. However, we did not find
specific MHC-I coprecipitation with open-CD3 induced by Ag-loaded APCs in either of two
class I-restricted TCRs tested (Fig. 5). Thus, we propose that TCR engagement by class I
Ags associated with APCs imposes some distinct property that stabilizes open-CD3 to
outlast TCR ligand dissociation (Fig. 7). According to mathematical models applied to
evaluate the role of serial engagement and kinetic proofreading in the process of TCR–CD3
internalization, the receptors must remain tagged for endocytosis after dissociation from Ags
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(35). Given that the PRS has been related to TCR–CD3 endocytosis, ubiquitylation, and
degradation (12, 14, 16, 36), an interesting possibility emerges that open-CD3 might mark
post-engaged receptors and link them in some way to endocytosis and/or recycling
processes.
Through its cytosolic BRS motif, the CD3ε tail has been proposed to interact with specific
phosphoinositides at the inner leaflet of the plasma membrane (18, 19). This interaction can
sustain a partial folding of the distal ITAM, embedding the tyrosine residues into the
hydrophobic core of the lipid bilayer (18). The possibility was suggested that the lipid-
bound BRS might cause the PRS to adopt its closed conformation, preventing its access to
cytosolic binding partners (23). However, a subsequent study of naive T cells containing
CD3ε molecules unable to complex lipids revealed only small differences in signaling
pathways in response to anti-CD3 and pMHC stimulations while suggesting a more
prominent role of the BRS in the regulation of TCR–CD3 recycling (19). To test whether the
BRS was required to conceal the PRS, we compared the contents of open-CD3 in mice
transgenic for CD3ε BRS WT and CD3ε BRS-Substitute sequences, the latter lacking BRS–
lipid binding capability (19).We found that regarding both basal open-CD3 (Fig. 6C) and
Ab-inducible open-CD3 (Fig. 6D), BRS-Substitute thymocytes were equal to their BRS WT
counterparts. Thus, the BRS does not appear to be required to cause PRS concealment in
closed-CD3 or to promote PRS exposure upon Ab stimulation.
In summary, in this study we present an updated model of the regulation of PRS
accessibility in thymocytes that unifies previous observations regarding the constitutive
versus inducible nature of PRS accessibility to Nck. First, we observe a basal level of open-
CD3 in thymocytes that is compatible with Ag-independent PRS participation in the
regulation of TCR–CD3 expression. Second, we demonstrate that antigenic engagement in
thymocytes elevates open-CD3 above basal levels, consistent with the idea that thymocytes
undergo CD3Δc upon stimulation. We also show that Ags expressed by APCs can induce
open-CD3 that outlasts ligand dissociation from the TCR. Finally, the BRS motif in CD3ε is
required for neither concealment nor exposure of the PRS. Future experimentation will
explore in greater detail the factors that influence basal open-CD3 and the duration and
function of CD3 conformations in T cells of various maturation states.
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Abbreviations used in this article
ABA 4-azidobenzoic acid
AF Alexa Fluor
B6 C57BL/6
BRS basic amino acid-rich stretch
CD3Δc CD3 conformational change
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CD3-PD CD3 pull-down
DP double-positive
Ham IgG hamster IgG isotype control
MHC-I MHC class I
pMHC peptide–MHC
PRS proline-rich sequence
TL total lysate
WB Western blot
WT wild-type
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FIGURE 1.
TCR–CD3 engagement induces open-CD3 in B6 thymocytes. B6 thymocytes were treated in
vitro with either Ham IgG (basal condition) or anti-CD3ε mAb 2C11 (stimulated condition).
Next, cells were lysed and either total lysate (TL) or CD3-PD assay samples were prepared
(see Materials and Methods), involving SDS-PAGE and WB for CD3ζ. Twenty-two
independent CD3-PD assays were performed, and open-CD3 induction was calculated in
each as the ratio of open-CD3 found in stimulated relative to basal conditions. A–C, Three
independent experiments are shown representing low (A), intermediate (B), and high (C)
levels of induced open-CD3 by 2C11 stimulation. D, Values of open-CD3 induction
achieved by 2C11 stimulation are plotted (mean = 4.7, median = 4.4, SD = 2.6, SE = 0.5).
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FIGURE 2.
Nonstimulated B6 thymocytes express basal levels of open-CD3. B6 thymocytes were
treated in vitro with either Ham IgG (basal condition) or anti-CD3ε mAb 2C11 (stimulated
condition). Then samples were subjected to the CD3-PD assay either in the presence or the
absence of the blocking mAb APA1/1 to compare the assay background with specific basal
and stimulated open-CD3. A, One representative experiment illustrating the amount of open-
CD3 in background, basal, and 2C11-stimulated conditions. The fold-increases are shown
relative to either background or basal open-CD3. B, Values of open-CD3 found in basal and
stimulated conditions are plotted relative to the CD3-PD assay background in 12
independent experiments. Lines represent the mean open-CD3 found in each condition; SE
bars for each condition are shown. Paired t tests were run to calculate p values; basal open-
CD3 is statistically different from background, and stimulated open-CD3 is statistically
different from basal. C, Mean of basal and stimulated amounts of open-CD3 established in
these 12 independent experiments relative to CD3-PD assay background are depicted.
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FIGURE 3.
Thymic MHC induces basal open-CD3 in WT thymocytes in vivo. Background, basal, and
stimulated samples were prepared from B6 WT or B6 Abb−/− β2m−/− thymocytes to
establish the amounts of open-CD3 using the CD3-PD assay. Amounts of open-CD3 relative
to either the CD3-PD assay background or basal conditions were calculated for both types of
thymocytes as in Fig. 2. Additionally, percent maximum (2C11 stimulation = 100%) was
calculated to facilitate the comparison of basal open-CD3 observed from each thymocyte
type. A, The measurements of open-CD3 found in B6 WT and Abb−/− β2m−/− mice from
one representative experiment are shown. B and C, Values of basal open-CD3 as a percent
maximum of 2C11 stimulation (B) and open-CD3 induction achieved by 2C11stimulation
over basal (C) are plotted for five independent experiments. The mean ± SE is displayed
representing the amount of open-CD3 found in thymocytes from each mouse type. Paired t
tests were run to calculate p values.
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FIGURE 4.
The mAb APA1/1 can bind to the CD3ε cytoplasmic tail independently of TCR–CD3
engagement. Flow cytometry via intracellular staining of the CD3ε PRS using the mAb
APA1/1 was performed in parallel to the CD3-PD assay in all nonstimulated and stimulated
samples shown in Fig. 3. Splenocytes from B6 Abb−/− β2m−/− mice were added to the
samples right after the stimulation, and before the fixation/permeabilization protocol, to
provide a non-T cell population and establish the background of this staining. A, Data are
from the same experiment shown in Fig. 3A. Histograms are displayed overlaying the CD3ε
PRS staining (with 1:2 dilution of APA1/1–PE) of thymocytes treated with either Ham IgG
(basal condition) or anti-CD3 mAb 2C11 (stimulated condition) for 15 min at 37°C. B and
C, CD3ε PRS stain in B6 WT (B) or Abb−/− β2m−/− (C) thymocytes with decreasing doses
of APA1/1–PE is displayed for data from the same experiment shown in Fig. 3A. D, OT-I
Rag2−/− β2m−/− thymocytes were labeled in the cold with anti-Thy1.2-biotin plus
streptavidin–AF-488, mixed with anti-Vα2 polystyrene latex beads (1:4 ratio), stimulated 30
min at 37°C, and treated with Cytofix/Cytoperm buffer. Samples were then mixed with B6
Abb−/− β2m−/− nonstimulated thymocytes that had been fixed and permeabilized in parallel.
The resulting samples were then stained intracellularly with APA1/1–AF-555 and mounted
on coverslips for confocal analysis. Micrographs display images at ~×60 magnification, and
the anti-Va2 bead is 5 µm in diameter.
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FIGURE 5.
Open-CD3 outlasts TCR engagement by APCs. A, OT-I Rag−/− β2m−/− preselection DP
thymocytes were cocultured for 30 min at 37°C with T2-Kb APCs that had been preloaded
with either pFARL (null peptide), pOVA (antigenic peptide), or no peptide plus soluble anti-
CD3ε mAb 2C11. Then, cocultures were lysed and subjected to the CD3-PD assay. CD3-PD
samples were visualized for their content of 2C11, MHC-I H chain, and CD3ζ by WB.
Open-CD3 inductions achieved by antigenic and 2C11 stimulation were calculated relative
to the amounts of open-CD3 found in basal conditions (pFARL). B, T1 hybridoma cells
were cocultured for 30 min with P-815 APCs that had been preloaded with either no peptide
(Ø), pSYIP (antigenic peptide), or no peptide plus soluble anti-CD3ε mAb 2C11. Then,
cocultures were lysed and subjected to the CD3-PD assay or H2-Kd immunoprecipitation
with the mAb SF1-1.1. CD3-PD samples were visualized for their content of 2C11, MHC-I
H chain, and CD3ζ by WB. Open-CD3 inductions achieved by antigenic and 2C11
stimulation were calculated relative to the amounts of open-CD3 found in basal conditions
(Ø).
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FIGURE 6.
The CD3ε BRS is not required to conceal the PRS in absence of TCR–CD3 engagement. A,
Schematic representation of the amino acid sequence of murine CD3ε and its domains with
either the WT (top) or the substitute (bottom) BRS sequence (EXTRA, extracellular; TM,
transmembrane; BRS, basic amino acid-rich stretch; PRS, proline-rich sequence; ITAM,
immunoreceptor tyrosine-based activation motif). B, Thymocytes from mice transgenic for
either CD3ε BRS WT or BRS-Substitute were lysed and subjected to the CD3-PD assay to
assess background, basal, and 2C11-stimulated open-CD3 levels as previously described. C
and D, Values of basal open-CD3 as a percent maximum of 2C11 stimulation (C) and of
open-CD3 induction achieved by 2C11 stimulation over basal (D) are plotted for six
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independent experiments. The mean ± SE is displayed representing the amount of open-CD3
found in thymocytes from each mouse type. Paired t tests were run to calculate p values,
which indicate that basal and open-CD3 induction in CD3ε BRS WT versus BRS-Substitute
thymocytes are not statistically different.
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FIGURE 7.
Model of the regulation of PRS accessibility in thymocytes. Based on the accessibility of the
CD3ε PRS to interact with the SH3.1 domain of Nck, we distinguish two conformations for
the CD3 complex: closed-CD3 is inaccessible, whereas open-CD3 is accessible. CD3Δc is
defined as the transition between these two alternative conformations (A, B). A, In a basal
state characterized by the absence of TCR engagement with pMHC ligands, there is a
minimum but positive amount of open-CD3. B, When TCR–CD3 is engaged by pMHC
ligands expressed by APCs, CD3Δc increases the level of open-CD3. C, This new level of
open-CD3 can endure beyond receptor engagement. Possible mechanistic and functional
roles for this series of events are discussed in the text.
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